HomeAQS • CVE
Aequus Pharmaceuticals Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 226.55K | 331.06% |
Operating expense | 224.01K | -65.30% |
Net income | -645.10K | 2.57% |
Net profit margin | -284.76 | 77.40% |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 39.17K | -83.82% |
Total assets | 304.22K | -72.15% |
Total liabilities | 7.41M | 22.75% |
Total equity | -7.11M | — |
Shares outstanding | 132.63M | — |
Price to book | -0.10 | — |
Return on assets | -39.63% | — |
Return on capital | 118.10% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (CAD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -645.10K | 2.57% |
Cash from operations | 31.71K | 106.08% |
Cash from investing | — | — |
Cash from financing | -42.78K | -107.21% |
Net change in cash | -11.07K | 86.09% |
Free cash flow | 80.59K | 127.87% |
Previous close
$0.0050
Year range
$0.0050 - $0.040
Market cap
663.90K CAD
Avg Volume
102.55K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
About
Founded
2013
Headquarters
Website
Employees
12
